Literature DB >> 23062569

Diabetes and cardiovascular disease: changing the focus from glycemic control to improving long-term survival.

Cecilia C Low Wang1, Jane E B Reusch.   

Abstract

Diabetes mellitus (DM) is the fifth-leading cause of death worldwide and contributes to leading causes of death, cancer and cardiovascular disease, including CAD, stroke, peripheral vascular disease, and other vascular disease. While glycemic management remains a cornerstone of DM care, the co-management of hypertension, atherosclerosis, cardiovascular risk reduction, and prevention of long-term consequences associated with DM are now well recognized as essential to improve long-term survival. Clinical trial evidence substantiates the importance of glycemic control, low-density cholesterol-lowering therapy, blood pressure lowering, control of albuminuria, and comprehensive approaches targeting multiple risk factors to reduce cardiovascular risk. This article presents a review of the role of DM in the pathogenesis of atherosclerosis and cardiac dysfunction, recent evidence on the degree of glycemic control and mortality, and available evidence for a multifaceted approach to improve long-term outcomes for patients. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23062569      PMCID: PMC3480668          DOI: 10.1016/j.amjcard.2012.08.036

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  83 in total

1.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

2.  Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction.

Authors:  D L Dries; N K Sweitzer; M H Drazner; L W Stevenson; B J Gersh
Journal:  J Am Coll Cardiol       Date:  2001-08       Impact factor: 24.094

3.  Lifestyle change and mobility in obese adults with type 2 diabetes.

Authors:  W Jack Rejeski; Edward H Ip; Alain G Bertoni; George A Bray; Gina Evans; Edward W Gregg; Qiang Zhang
Journal:  N Engl J Med       Date:  2012-03-29       Impact factor: 91.245

4.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

Authors: 
Journal:  Lancet       Date:  2000-01-22       Impact factor: 79.321

5.  Impact of diabetes on cardiac structure and function: the strong heart study.

Authors:  R B Devereux; M J Roman; M Paranicas; M J O'Grady; E T Lee; T K Welty; R R Fabsitz; D Robbins; E R Rhoades; B V Howard
Journal:  Circulation       Date:  2000-05-16       Impact factor: 29.690

6.  Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry.

Authors:  K Malmberg; S Yusuf; H C Gerstein; J Brown; F Zhao; D Hunt; L Piegas; J Calvin; M Keltai; A Budaj
Journal:  Circulation       Date:  2000-08-29       Impact factor: 29.690

7.  Diabetes and incident heart failure in hypertensive and normotensive participants of the Strong Heart Study.

Authors:  Giovanni de Simone; Richard B Devereux; Marcello Chinali; Elisa T Lee; James M Galloway; Ana Barac; Julio A Panza; Barbara V Howard
Journal:  J Hypertens       Date:  2010-02       Impact factor: 4.844

8.  Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function.

Authors:  Kristen J Nadeau; Judith G Regensteiner; Timothy A Bauer; Mark S Brown; Jennifer L Dorosz; Amber Hull; Phil Zeitler; Boris Draznin; Jane E B Reusch
Journal:  J Clin Endocrinol Metab       Date:  2009-11-13       Impact factor: 5.958

9.  The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study.

Authors:  Denise E Bonds; Michael E Miller; Richard M Bergenstal; John B Buse; Robert P Byington; Jeff A Cutler; R James Dudl; Faramarz Ismail-Beigi; Angela R Kimel; Byron Hoogwerf; Karen R Horowitz; Peter J Savage; Elizabeth R Seaquist; Debra L Simmons; William I Sivitz; Joann M Speril-Hillen; Mary Ellen Sweeney
Journal:  BMJ       Date:  2010-01-08

10.  The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study.

Authors:  Michael E Miller; Denise E Bonds; Hertzel C Gerstein; Elizabeth R Seaquist; Richard M Bergenstal; Jorge Calles-Escandon; R Dale Childress; Timothy E Craven; Robert M Cuddihy; George Dailey; Mark N Feinglos; Farmarz Ismail-Beigi; Joe F Largay; Patrick J O'Connor; Terri Paul; Peter J Savage; Ulrich K Schubart; Ajay Sood; Saul Genuth
Journal:  BMJ       Date:  2010-01-08
View more
  26 in total

1.  A ligand-independent VEGFR2 signaling pathway limits angiogenic responses in diabetes.

Authors:  Carmen M Warren; Safiyyah Ziyad; Anaïs Briot; Aaron Der; M Luisa Iruela-Arispe
Journal:  Sci Signal       Date:  2014-01-07       Impact factor: 8.192

2.  Individualizing HbA1c targets for patients with diabetes: impact of an automated algorithm within a primary care network.

Authors:  S A Berkowitz; S J Atlas; R W Grant; D J Wexler
Journal:  Diabet Med       Date:  2014-04-11       Impact factor: 4.359

Review 3.  Diabetic aggravation of stroke and animal models.

Authors:  Ashish K Rehni; Allen Liu; Miguel A Perez-Pinzon; Kunjan R Dave
Journal:  Exp Neurol       Date:  2017-03-06       Impact factor: 5.330

4.  Comparison of ranolazine and trimetazidine on glycemic status in diabetic patients with coronary artery disease - a randomized controlled trial.

Authors:  Selvarajan Sandhiya; Steven Aibor Dkhar; Ajith Ananthakrishna Pillai; Melvin George; Balachander Jayaraman; Adithan Chandrasekaran
Journal:  J Clin Diagn Res       Date:  2015-01-01

Review 5.  Protective mechanisms of mitochondria and heart function in diabetes.

Authors:  Miguel A Aon; Carlo G Tocchetti; Niraj Bhatt; Nazareno Paolocci; Sonia Cortassa
Journal:  Antioxid Redox Signal       Date:  2015-03-31       Impact factor: 8.401

6.  Vildagliptin stimulates endothelial cell network formation and ischemia-induced revascularization via an endothelial nitric-oxide synthase-dependent mechanism.

Authors:  Masakazu Ishii; Rei Shibata; Kazuhisa Kondo; Takahiro Kambara; Yuuki Shimizu; Tohru Tanigawa; Yasuko K Bando; Masahiro Nishimura; Noriyuki Ouchi; Toyoaki Murohara
Journal:  J Biol Chem       Date:  2014-08-06       Impact factor: 5.157

Review 7.  Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations.

Authors:  Cecilia C Low Wang; Connie N Hess; William R Hiatt; Allison B Goldfine
Journal:  Circulation       Date:  2016-06-14       Impact factor: 29.690

Review 8.  Hyperglycemia / hypoglycemia-induced mitochondrial dysfunction and cerebral ischemic damage in diabetics.

Authors:  Ashish K Rehni; Neha Nautiyal; Miguel A Perez-Pinzon; Kunjan R Dave
Journal:  Metab Brain Dis       Date:  2014-04-16       Impact factor: 3.584

Review 9.  Structural changes in the myocardium during diabetes-induced cardiomyopathy.

Authors:  Ernest Adeghate; Jaipaul Singh
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

Review 10.  Mechanisms governing the health and performance benefits of exercise.

Authors:  D Bishop-Bailey
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.